Euglycemic Ketoacidosis in a Patient with Metastatic Non-Small-Cell Lung Adenocarcinoma and Concomitant Pulmonary Embolism

Euglycemic ketoacidosis is a recognised side effect secondary to sodium-glucose cotransporter 2 inhibitor use in the treatment of type 2 diabetes mellitus; however, there is scarce evidence to suggest whether preexisting comorbid conditions contribute to the development of this potentially life-thre...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Neill, Robert Sean, Tyack, Lauren, Freeman, Mary, Hussein, Hussein Soudy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429761/
https://www.ncbi.nlm.nih.gov/pubmed/32832169
http://dx.doi.org/10.1155/2020/8882299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429761/
https://www.ncbi.nlm.nih.gov/pubmed/32832169
http://dx.doi.org/10.1155/2020/8882299

Ejemplares similares